Navigation Links
Pharmaceutical use in Norwegian fish farming in 2001-2007
Date:4/28/2008

The Norwegian Institute of Public Health has published an overview of sales of various drugs used in fish breeding in Norway from 2001-2007. The sales are shown in kilograms of active ingredient; antibacterials, anaesthetics, anthelmintics and treatments for sea lice and fungi. The figures are based on sales from wholesalers to pharmacies and from feed mills to breeders.

After an increase in sales of antibacterials from 2002-2006, sales in 2007 returned to levels seen in 2001. Prescription-based statistics from the Norwegian Food Safety Authority for the period 2000-2006 show that this increase can be blamed on new breeding species, especially cod. However, the increase in use for cod was positively correlated to the increase in biomass cod produced.

For more detailed data, including tables of information view the full news article on the NIPH's website located at http://www.fhi.no/eway/default.aspx?pid=238&trg=Area_5954&MainLeft_5812=5954:0:&Area_5954=5825:68486::0:5955:1:::0:0.


'/>"/>

Contact: Media Contact
info@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

Page: 1

Related biology news :

1. Pharmaceutical breakthrough may make a range of drugs cheaper and more available
2. Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design
3. NMR researchers unlock hydrogens secrets to spot polymorphism in pharmaceuticals
4. Biopharmaceutical infrastructure key to lower drug development costs
5. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
6. Bacteria from sponges make new pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... 2017 Sandata Technologies, LLC, a leading ... industry, including Electronic Visit Verification™ (EVV™), announced today ... as Senior Vice President of Product Management. ... homecare experience to Sandata, where he will be ... align Sandata,s suite of solutions with the needs ...
(Date:1/12/2017)... , January 12, 2017 A new report by Allied ... that the global biometric technology market is expected to generate revenue of $10.72 billion ... Continue Reading ... Allied Market Research ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... -- WuXi AppTec, a leading global pharmaceutical, biotechnology ... today announced that it has acquired HD Biosciences ... contract research organization (CRO). After completion of acquisition, ... WuXi, and will continue to focus on growing ... acquisition will further strengthen WuXi,s R&D capability from ...
(Date:1/19/2017)... Switzerland (PRWEB) , ... January ... ... provider of advanced software solutions for pharmaceutical research and development (R&D), today ... expertise in omic data analysis and interpretation for the rapidly evolving field ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , ... PIP) and Altimmune, Inc., a privately-held immunotherapeutics company ... a definitive agreement for the merger of PharmAthene ... investors include Novartis Venture Fund, HealthCap, Truffle Capital ... a fully-integrated and diversified immunotherapeutics company with four ...
(Date:1/19/2017)... Mass. , Jan. 19, 2017 AquaBounty ... focused on enhancing productivity in aquaculture and a majority-owned ... announces that it has completed the listing of its ... the equity subscription from Intrexon. "AquaBounty,s listing ... that will broaden our exposure to the U.S. markets ...
Breaking Biology Technology: